Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism

Drugs. 1976;11(5):329-77. doi: 10.2165/00003495-197611050-00001.
No abstract available

Publication types

  • Review

MeSH terms

  • Benserazide / administration & dosage
  • Benserazide / adverse effects
  • Benserazide / metabolism
  • Benserazide / pharmacology*
  • Benserazide / therapeutic use
  • Binding Sites / drug effects
  • Carbidopa / administration & dosage
  • Carbidopa / adverse effects
  • Carbidopa / metabolism
  • Carbidopa / pharmacology*
  • Carbidopa / therapeutic use
  • Carboxy-Lyases / antagonists & inhibitors*
  • Drug Interactions
  • Humans
  • Hydrazines / pharmacology*
  • Kinetics
  • Levodopa / administration & dosage
  • Levodopa / metabolism
  • Levodopa / pharmacology*
  • Levodopa / therapeutic use
  • Liver Function Tests
  • Parkinson Disease / drug therapy*

Substances

  • Hydrazines
  • Levodopa
  • Benserazide
  • Carboxy-Lyases
  • Carbidopa